Literature DB >> 18160621

Monoclonal antibodies that bind to common epitopes on the dengue virus type 2 nonstructural-1 and envelope glycoproteins display weak neutralizing activity and differentiated responses to virulent strains: implications for pathogenesis and vaccines.

Andrew K I Falconar1.   

Abstract

The abilities of monoclonal antibodies (MAbs) that bind to defined sequential epitopes on the dengue virus (DENV) nonstructural-1 (NS1) glycoproteins to cross-react with epitopes on the DENV envelope (E) glycoproteins were investigated. In this study, some of these MAbs cross-reacted with the DENV type 2 (DENV-2) E glycoprotein and with synthetic peptides representing X-ray crystallographically confirmed surface-exposed regions on this glycoprotein. MAb 1G5.3 cross-reacted with the flavivirus-conserved 101-WGNGCGLFG-109 fusion sequence, the 273-SSGNL-277 DENV-2 hinge region sequence, and the 156-GKHGKEIKIT-165 sequence of virulent DENV-2 strains. MAb 1G5.4-A1-C3 cross-reacted with the 67-NTTTESRCPT-76 and 156-GKHGKEIKIT-165 sequences of virulent DENV-2 strains, the 338-EIMDLDNRHV-347 sequence from a highly virulent DENV-2 (M2) strain, and two epitopes on a virulent DENV-3 strain (288-KMDKLELKG-296 and 323-RVEYRGEDAP-332), which all contained target ELK/KLE-type motifs (underlined). These MAbs showed reduced cross-reactions with the corresponding sequences from weakly pathogenic strains of all four DENV serotypes and had either no (MAb 1G5.4-A1-C3) or weak (MAb 1G5.3) neutralizing activity against them. MAb 1G5.3 more strongly neutralized DENV-2 strains with higher pathogenic capacities, while MAb 1G5.4-A1-C3 showed increasing neutralizing titers against the virulent DENV-3 strain and the moderately virulent and highly virulent (M2) DENV-2 strains. These cross-reactions with the E glycoprotein accord with the observation that MAb 1G5.3 caused dramatic and lethal antibody-enhanced replication (AER) of a DENV-2 strain in vivo. Together with in vivo AER studies of these DENV strains using MAb 1G5.4-A1-C3, these results may account for the increased pathogenic capacities of such strains, which is likely to have important implications for pathogenesis and vaccines.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18160621      PMCID: PMC2268263          DOI: 10.1128/CVI.00351-07

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  41 in total

1.  Identification of an epitope on the dengue virus membrane (M) protein defined by cross-protective monoclonal antibodies: design of an improved epitope sequence based on common determinants present in both envelope (E and M) proteins.

Authors:  A K Falconar
Journal:  Arch Virol       Date:  1999       Impact factor: 2.574

2.  Molecular epidemiology of dengue type 2 virus in Venezuela: evidence for in situ virus evolution and recombination.

Authors:  N Y Uzcategui; D Camacho; G Comach; R Cuello de Uzcategui; E C Holmes; E A Gould
Journal:  J Gen Virol       Date:  2001-12       Impact factor: 3.891

3.  Identification of epitopes on the envelope (E) protein of dengue 2 and dengue 3 viruses using monoclonal antibodies.

Authors:  I L Serafin; J G Aaskov
Journal:  Arch Virol       Date:  2001-12       Impact factor: 2.574

4.  Amino acid and phenotypic changes in dengue 2 virus associated with escape from neutralisation by IgM antibody.

Authors:  S M Lok; M L Ng; J Aaskov
Journal:  J Med Virol       Date:  2001-10       Impact factor: 2.327

5.  Molecular epidemiology of dengue virus type 3 in Venezuela.

Authors:  N Y Uzcategui; G Comach; D Camacho; M Salcedo; M Cabello de Quintana; M Jimenez; G Sierra; R Cuello de Uzcategui; W S James; S Turner; E C Holmes; E A Gould
Journal:  J Gen Virol       Date:  2003-06       Impact factor: 3.891

6.  Phylogenetic relationships and differential selection pressures among genotypes of dengue-2 virus.

Authors:  S Susanna Twiddy; Jeremy J Farrar; Nguyen Vinh Chau; Bridget Wills; Ernest A Gould; Tamara Gritsun; Graham Lloyd; Edward C Holmes
Journal:  Virology       Date:  2002-06-20       Impact factor: 3.616

7.  A ligand-binding pocket in the dengue virus envelope glycoprotein.

Authors:  Yorgo Modis; Steven Ogata; David Clements; Stephen C Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-20       Impact factor: 11.205

8.  High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever.

Authors:  Daniel H Libraty; Paul R Young; Darren Pickering; Timothy P Endy; Siripen Kalayanarooj; Sharone Green; David W Vaughn; Ananda Nisalak; Francis A Ennis; Alan L Rothman
Journal:  J Infect Dis       Date:  2002-09-16       Impact factor: 5.226

9.  American genotype structures decrease dengue virus output from human monocytes and dendritic cells.

Authors:  Raymond Cologna; Rebeca Rico-Hesse
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

Review 10.  Dengue and dengue hemorrhagic fever.

Authors:  D J Gubler
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

View more
  16 in total

1.  B-cell responses during primary and secondary dengue virus infections in humans.

Authors:  Anuja Mathew; Kim West; Siripen Kalayanarooj; Robert V Gibbons; Anon Srikiatkhachorn; Sharone Green; Daniel Libraty; Smita Jaiswal; Alan L Rothman
Journal:  J Infect Dis       Date:  2011-09-19       Impact factor: 5.226

2.  Antibodies induced by dengue virus type 1 and 2 envelope domain III recombinant proteins in monkeys neutralize strains with different genotypes.

Authors:  Lidice Bernardo; Osmel Fleitas; Alequis Pavón; Lisset Hermida; Gerardo Guillén; Maria G Guzman
Journal:  Clin Vaccine Immunol       Date:  2009-09-02

3.  Antibody recognition of the dengue virus proteome and implications for development of vaccines.

Authors:  Stefan Fernandez; Emily D Cisney; Alexander P Tikhonov; Barry Schweitzer; Robert J Putnak; Monika Simmons; Robert G Ulrich
Journal:  Clin Vaccine Immunol       Date:  2011-01-26

4.  Flavivirus NS1 structures reveal surfaces for associations with membranes and the immune system.

Authors:  David L Akey; W Clay Brown; Somnath Dutta; Jamie Konwerski; Joyce Jose; Thomas J Jurkiw; James DelProposto; Craig M Ogata; Georgios Skiniotis; Richard J Kuhn; Janet L Smith
Journal:  Science       Date:  2014-02-06       Impact factor: 47.728

5.  A highly conserved region between amino acids 221 and 266 of dengue virus non-structural protein 1 is a major epitope region in infected patients.

Authors:  Magot Diata Omokoko; Sabar Pambudi; Supranee Phanthanawiboon; Promsin Masrinoul; Chayanee Setthapramote; Tadahiro Sasaki; Motoki Kuhara; Pongrama Ramasoota; Akifumi Yamashita; Itaru Hirai; Kazuyoshi Ikuta; Takeshi Kurosu
Journal:  Am J Trop Med Hyg       Date:  2014-04-28       Impact factor: 2.345

6.  Evolution of dengue virus type 3 genotype III in Venezuela: diversification, rates and population dynamics.

Authors:  Alvaro Ramírez; Alvaro Fajardo; Zoila Moros; Marlene Gerder; Gerson Caraballo; Daria Camacho; Guillermo Comach; Victor Alarcón; Julio Zambrano; Rosa Hernández; Gonzalo Moratorio; Juan Cristina; Ferdinando Liprandi
Journal:  Virol J       Date:  2010-11-18       Impact factor: 4.099

7.  The NS1 glycoprotein can generate dramatic antibody-enhanced dengue viral replication in normal out-bred mice resulting in lethal multi-organ disease.

Authors:  Andrew K I Falconar; Fernando Martinez
Journal:  PLoS One       Date:  2011-06-22       Impact factor: 3.240

8.  Epitope reactions can be gauged by relative antibody discriminating specificity (RADS) values supported by deletion, substitution and cysteine bridge formation analyses: potential uses in pathogenesis studies.

Authors:  Andrew K I Falconar
Journal:  BMC Res Notes       Date:  2012-07-05

9.  Mapping the interactions of dengue virus NS1 protein with human liver proteins using a yeast two-hybrid system: identification of C1q as an interacting partner.

Authors:  Emiliana M Silva; Jonas N Conde; Diego Allonso; Mauricio L Nogueira; Ronaldo Mohana-Borges
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

10.  A simple, inexpensive, robust and sensitive dot-blot assay for equal detection of the nonstructural-1 glycoprotein of all dengue virus serotypes.

Authors:  Andrew K I Falconar; Claudia M E Romero-Vivas
Journal:  Virol J       Date:  2013-04-22       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.